Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)

Clinical trial NCT00517920 · COMPLETED

Trial details

NCT number: NCT00517920
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2007-09-01
Primary completion: 2011-06-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.